HALKUFF DAWN sold 27.0% of their position (42.50K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $309.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2025ACC: 0001867096-25-000138
Director
Since Oct 2021
-42.50K
Net shares
Net seller
$309.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
42.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−42.50K
Price / share
$7.28
Trade value
$309.23K
% of position
27.0%
8/12/2025
157.50K→115K
Total
Net shares
−42.50K
Net value
-$309.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2025 | S · Sale | −42.50K | $7.28 | $309.23K | 27.0% | 157.50K | 115K |
| Total | −42.50K | -$309.23K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.41K
Total
5.41K indirect5.41K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.41K | Indirect |
| Total | 5.41K | 5.41K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported